Dynavax Technologies Corporation

NASDAQ:DVAX

13.52 (USD) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000
Revenue 232.284722.683439.44246.55135.2198.1980.32711.0434.0511.03211.2519.71421.61423.9540.31837.09414.0934.84714.65514.8120.8261.4272.3590
Cost of Revenue 50.167262.153173.57213.9119.38921.7961.194000000.2990.980.980.981.0040.698000000
Gross Profit 182.117460.53265.8732.64115.83-13.598-0.86711.0434.0511.03211.2519.71421.31522.9739.33836.11413.0894.14914.65514.8120.8261.4272.3590
Gross Profit Ratio 0.7840.6370.6050.7010.449-1.659-2.651111110.9860.9590.9760.9740.9290.856111110
Reseach & Development Expenses 54.88646.632.22828.60762.33174.95164.98884.49386.94384.5850.8749.14651.32253.6838.70844.77165.88850.11627.88723.12914.38115.96517.3638.267
General & Administrative Expenses 152.946131.408100.15679.25648.71764.7727.36737.25722.1817.76326.86928.16417.5716.87915.74515.46318.29314.8369.2588.5430000
Selling & Marketing Expenses 00024.75926.26931.7587.61100000000000000000
SG&A 152.946131.408100.15679.25674.98664.7727.36737.25722.1817.76326.86928.16417.5716.87915.74515.46318.29314.8369.2588.5434.2094.1214.5273.451
Other Expenses 11.3137.7968.6576.8093.35-0.07-0.486-2.4920.3170.433-0.348-0.2930.2990.980.980.981.0040.698000000
Operating Expenses 207.832178.008132.384107.863137.317139.72193.549121.75109.123102.34377.73977.3169.19171.53955.43361.21485.18565.6537.14531.67218.5920.08621.8911.718
Operating Income -37.028283.522134.486-75.222-121.487-153.319-96.005-110.707-105.073-91.311-66.488-67.596-47.577-47.589-15.115-24.12-71.092-64.983-22.49-16.86-17.764-18.659-19.531-9.664
Operating Income Ratio -0.1590.3920.306-1.616-3.449-18.702-293.593-10.025-25.944-8.277-5.91-6.959-2.201-1.987-0.375-0.65-5.044-13.407-1.535-1.138-21.506-13.076-8.2790
Total Other Income Expenses Net 32.66110.777-56.965-6.869-17.757-5.580.851-1.737-1.7210.589-0.232-2.353-1.02-9.719-0.012-2.4162.4463.1881.9350.889-0.274019.5310
Income Before Tax -4.367294.29977.521-75.24-152.6-158.899-95.154-112.444-106.794-90.722-66.72-69.949-48.597-57.308-30.565-20.829-59.971-52.052-20.555-15.971-18.038000
Income Before Tax Ratio -0.0190.4070.176-1.616-4.333-19.383-290.991-10.182-26.369-8.224-5.93-7.201-2.248-2.393-0.758-0.562-4.255-10.739-1.403-1.078-21.838000
Income Tax Expense 2.0221.1430.80816.536-1.2033.7581.446-3.012-0.476-0.936-0.1160.8511.029.7190-3.2910.372-8.75100-0.686-0.62118.41217.06
Net Income -6.389293.15676.713-91.776-151.397-158.899-95.154-112.444-106.794-90.722-66.72-69.949-48.597-57.308-30.565-20.829-59.971-52.052-20.555-15.971-17.352-18.038-18.412-26.724
Net Income Ratio -0.0280.4060.175-1.972-4.299-19.383-290.991-10.182-26.369-8.224-5.93-7.201-2.248-2.393-0.758-0.562-4.255-10.739-1.403-1.078-21.007-12.641-7.8050
EPS -0.052.320.62-0.91-2.1-2.55-1.81-2.92-3.25-3.45-3.4-4.1-3.88-6.95-7.57-5.23-15.09-16.1-7.93-7.54-96.88-106.04-122.91-225.9
EPS Diluted -0.051.970.54-0.91-2.1-2.55-1.81-2.92-3.25-3.45-3.4-4.1-3.88-6.95-7.57-5.23-15.09-16.1-7.93-7.54-96.24-106.04-122.91-225.9
EBITDA 9.666307.69995.708-46.843-114.093-135.078-90.716-110.187-104.857-89.283-65.393-66.391-45.038-53.259-12.166-21.29-71.092-60.665-19.358-15.435-17.188-17.981-19.531-11.718
EBITDA Ratio 0.0420.4130.324-1.443-3.259-18.244-272.92-10.025-25.815-8.22-5.792-6.959-2.166-1.547-0.305-0.709-4.973-11.366-1.321-0.917-20.809-12.601-8.2790